Grace

RSV Vaccine Study

Main objective:

This study will be enrolling pregnant women to receive an investigational vaccine intended to reduce the frequency of RSV infections in newborns.

Who are we looking for?

24-34 weeks of pregnancy
No major health problems in mother/fetus
Interested in possible reduction of chance of RSV pneumonia in baby
Willing to have infant followed for first year of life

What’s provided for duration of study:

Investigational vaccine administered to mother
Close follow-up of infant for 1 year
Modest payments for visits pre/post birth
Opportunity to help reduce incidence of RSV pneumonia

CONTACT US

If you would like additional information, please send us an email or give us a call!

334-504-7020

volunteerinfo@secclinicalresearch.com

Thank you for your interest – we look forward to hearing from you!